Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion type Assertion NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_head.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion wasGeneratedBy ECO_0000203 NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_provenance.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion wasDerivedFrom befree-2016 NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_provenance.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion SIO_000772 9742914 NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_provenance.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion evidence source_evidence_literature NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_provenance.
- NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_assertion description "[Treatment with high-dose bolus IL-2 mediates complete cancer regression in approximately 8% of patients with metastatic renal cancer and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404178.RALiA-nWzGTst8QrpHJtsEekG4Z7eZ9oJaCiKBbC6dbnk130_provenance.